Clinical exploration of ketamine for mental health outcomes in pediatric patients, highlighting its potential benefits.
The use of psychedelics for various mental health applications goes back at least to the 1960s. But clinical and research use became a casualty of the war on drugs by criminalizing their use, even in tightly controlled research settings. New thinking in this area has ignited a new era of clinical and research exploration. This paper will focus on the use of ketamine in a complex pediatric patient on an inpatient psychiatric unit.
No takes yet. Share an insight, caveat, or question.
Aljabari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: